biotech fireworks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech fireworks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	6/26/2009 1:55:40 PM
	Read Replies (1) of 7424

ISTA up about 35% 11:00AM ISTA Pharm trading resumes (ISTA) 5.46 +1.22 : 10:29AM ISTA Pharm confirms Dermatologic and Ophthalmic Drugs Advisory Committee unanimously recommends Bepreve for the treatment of ocular itching (ISTA) 4.24 +0.19 : Co announces the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the FDA recommended the approval of Bepreve (bepotastine besilate ophthalmic solution) 1.5% as an eye drop treatment for ocular itching associated with allergic conjunctivitis. The Committee voted unanimously 7 to 0 in favor of approving Bepreve after reviewing comprehensive safety and efficacy data from ISTA's clinical program. (Stock is halted)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next